- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03792399
Continuous Glucose Monitoring With Immediate or Delayed Counseling Feedback
Impact of Innovative Technology on Geriatric Diabetic Patients: Evaluation of Quality of Life, Self Efficacy and Glycemic Control Among Patients With Experience of Continuous Glucose Monitoring
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
After scheduled routine professional continuous glucose monitoring (CGM) exam, participants in both the intervention and control group receive ordinary education and regimen adjustment as indicated based on CGM results. For participants in the intervention group, they will also receive CGM counseling immediately on the day of CGM sensor removal. For participants in the control group, they will receive CGM counseling on the day of routine 3 months outpatient visit.
Qualitative data are collected through in-depth interview: User expectation, acceptability and satisfaction of CGM are also explored during in-depth interview with a semi-structured questionnaire.
Quantitative data were collected through validated questionnaires, including evaluation of depression by a short form of the Center for Epidemiologic Studies Depression Scale Revised (CES-D-R), emotional stress by Problem Areas in Diabetes Scale (PAID), self efficacy by Stanford Self-Efficacy for Diabetes (SES), at pretest and 3 months after CGM counseling.
Anthropometric Measurements. Body height, body weight, body mass index, and blood pressure were recorded at pre-test and post-test interview.
Blood Tests. Routine biochemistry, fasting plasma glucose, hemoglobin A1c (HbA1c) are collected within 2 weeks of pretest and posttest day.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Age 45 years old or more at recent outpatient visits;
- Type 2 diabetic patients followed up at National Cheng Kung University Hospital;
- Patients planned to receive CGM suggested by primary care physician due to inadequate controlled blood glucose.
Exclusion Criteria:
- Patients with diagnosis of generalized inflammation, advanced malignancy, end-stage renal disease on regular dialysis, status post renal transplantation, end-stage liver, heart or pulmonary disease;
- Patients who are taking systemic glucocorticoids;
- Any acute or chronic inflammatory disease as determined by a leukocyte count over 10,000/mm3 or clinical signs of infection;
- Patients who could not complete the questionnaires or who could not follow order due to cognitive impairment or in bed-ridden status;
- Patients diagnosed as thalassemia, glucose-6-phosphate dehydrogenase deficiency, and any other hemoglobinopathies that may influence the accuracy of hemoglobulin A1c measurement were also excluded. Patients who received blood transfusion in recent 3 months were also excluded.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Immediate feedback counseling
Professional CGM calibrate blood glucose via a glucsoe-oxidase-impregnated membrane during a 5 day period.
The patient wearing professional CGM is randomized to immediate feedback after data downloaded into computer.
|
Professoinal CGM in combination with diet and exercise record is used as teaching material to help patient realize their blood glucose pattern and to modify their behavior after counseling feedback.
|
Ander: Delayed feedback counseling
Professional CGM calibrate blood glucose via a glucsoe-oxidase-impregnated membrane during a 5 day period.
The patient wearing professional CGM is randomized to delayed feedback (standard care, i.e., CGM graphs interpretation at scheduled 3 months outpatient visit).
|
Professoinal CGM in combination with diet and exercise record is used as teaching material to help patient realize their blood glucose pattern and to modify their behavior after counseling feedback.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change of HbA1c
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Change of HbA1c in 3 months after CGM counseling.
|
Baseline and 3 months after CGM counseling
|
Change of score for self efficacy
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Change of Stanford Self-Efficacy for Diabetes Scale (SES) in 3 months after CGM counseling.
The score for each item ranged from 1-10.
The score of the scale is the mean of the eight items.
Higher number indicated higher self-efficacy.
|
Baseline and 3 months after CGM counseling
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change of score for diabetes associated stress
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Change of score for Problem Areas in Diabetes Scale (PAID) in 3 months after CGM counseling.
PAID is a 20-item self-reported questionnaire with scale 0-4 for each question, generating a total score of 0-100.
A score of ≥ 40 is defined as emotional burnout.
|
Baseline and 3 months after CGM counseling
|
Change of score for depression
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Change of score for Center for Epidemiologic Studies Depression Scale Revised (CESD-R) in 3 months after CGM counseling.
With 10-ietm CESD-R scale scoring 10 or more defined as having depression (range 0 to 30).
|
Baseline and 3 months after CGM counseling
|
Change in diet composition
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Change of carbohydrate amounts, fruits amount in 3 months after CGM counseling.
|
Baseline and 3 months after CGM counseling
|
Change in exercise amount, time spent in light activity
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in light activity per day in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
Change in exercise amount, time spent in moderate activity
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in moderate activity per day in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
Change in exercise amount, time spent in intense activity
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in intense activity per day in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
Change in exercise amount (time spent in sedentary behavior)
Tijdsspanne: Baseline and 3 months after CGM counseling
|
Exercise amount recorded by acelerometers, built in sports bracelet (Fitbit Charge HRTM Wireless Heart Rate + Activity Wristband).
Time spent in sedentary behavior in 3 months after CGM counseling feedback is compared with baseline.
|
Baseline and 3 months after CGM counseling
|
Medewerkers en onderzoekers
Onderzoekers
- Studie directeur: Ching-Ju Chiu, Ph.D., Institute of Gerontology, NCKU
- Hoofdonderzoeker: Ye-Fong Du, M.D., NCKUH
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- NCKUH-10508011
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Type 2 diabetes
-
Alexandra Kautzky-WillerBayerWervingVette lever | Hypogonadisme, man | Overgewicht/obesitas | Prediabetes/Type2 diabetes mellitusOostenrijk
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.VoltooidDiabetes mellitus, type 1 | Diabetes type 1 | Diabetestype1 | Diabetes mellitus type 1 | Auto-immuun diabetes | Diabetes Mellitus, insulineafhankelijk | Jeugddiabetes | Diabetes, auto-immuunziekte | Insulineafhankelijke diabetes mellitus 1 | Diabetes Mellitus, insulineafhankelijk, 1 | Diabetes Mellitus,... en andere voorwaardenVerenigde Staten
-
Guang NingWervingDiabetes mellitus type 2 | Diabetes mellitus type 1 | Monogene diabetes | Pancreatogene diabetes | Door medicijnen veroorzaakte diabetes mellitus | Andere vormen van diabetes mellitusChina
-
Medical College of WisconsinMedical University of South CarolinaVoltooidSuikerziekte | Diabetes mellitus type 2 | Diabetes Mellitus bij volwassenen | Niet-insulineafhankelijke diabetes mellitus | Niet-insulineafhankelijke diabetes mellitus, type IIVerenigde Staten
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationWervingDiabetes mellitus type 2 met complicatiesIndië
-
SanofiVoltooidDiabetes mellitus type 1 - Diabetes mellitus type 2Hongarije, Russische Federatie, Duitsland, Polen, Japan, Verenigde Staten, Finland
-
Meir Medical CenterVoltooidDiabetes mellitus type 2 | Diabetes Mellitus, niet-insulineafhankelijk | Diabetes Mellitus, over orale hypoglycemische behandeling | Diabetes Mellitus bij volwassenenIsraël
-
Peking Union Medical College HospitalOnbekendDiabetes mellitus type 2 | Diabetes mellitus type 1 | Zwangerschapsdiabetes mellitus | Pancreatogene diabetes mellitus | Pregestationele diabetes mellitus | Diabetespatiënten in de perioperatieve periodeChina
-
University of Colorado, DenverVoltooidDiabetes mellitus, type 1 | Diabetische nefropathieën | Diabetes mellitus type 1 | Diabetes Mellitus-complicatie | Nefropathie | Auto-immuun diabetes | JeugddiabetesVerenigde Staten
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Actief, niet wervendDiabetes mellitus, type 2 | Diabetes mellitus, Type II | Diabetes Mellitus, aanvang op volwassen leeftijd | Diabetes Mellitus, niet-insulineafhankelijk | Diabetes Mellitus, niet-insuline-afhankelijkVerenigde Staten
Klinische onderzoeken op feedback counseling
-
Universitätsklinikum Hamburg-EppendorfFederal Joint CommitteeVoltooid
-
Brainmarc Ltd.Onbekend
-
University of North Carolina, Chapel HillNational Institute on Deafness and Other Communication Disorders (NIDCD)VoltooidAfasie | Cerebrovasculair ongeval | Apraxie van spraakVerenigde Staten
-
Semmelweis UniversityWervingReanimatie | Basis levensondersteuning | Premedisch onderwijs | StudievaardighedenHongarije
-
Pusan National University HospitalVoltooidFysieke activiteit | Metaboolsyndroom | Draagbaar apparaatKorea, republiek van
-
Aveiro UniversityVoltooidOnderrug pijnPortugal
-
Massachusetts General HospitalRobert Wood Johnson FoundationVoltooidEtikettering van voedselVerenigde Staten
-
KEMRI-Wellcome Trust Collaborative Research ProgramVoltooid
-
University of British ColumbiaNational Council of Science and Technology, Mexico; UBC Peter Wall Institute...Voltooid
-
Yale UniversityNational Institute on Drug Abuse (NIDA)BeëindigdAan opioïden gerelateerde aandoeningenVerenigde Staten